Logo

Shareholders Clear PerkinElmer Acquisition of Packard BioScience

Sep 27, 2001

NEW YORK, Sept. 27 - PerkinElmer is now one step closer to acquiring Packard BioScience after shareholders from both firms approved the deal, the companies said in a joint statement on Thursday.

The merger, announced in July and reported by GenomeWeb , still remains subject to customary closing conditions and regulatory approvals, including approval by the Federal Trade Commission.

The companies expect to tie the knot in the fourth quarter.

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.